AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zuriglim MV 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Zurinovo Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Zuriglim MV 2mg/500mg/0.3mg Tablet

Diabetol Trio 2mg/500mg/0.3mg tablets are antidiabetic medications combining three agents to manage type 2 diabetes in adults. These tablets help regulate blood glucose. Diabetol Trio should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial; discontinuation without physician consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and trembling, and know how to counteract them with a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to check blood cell counts and liver function.

Uses of Zuriglim MV 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Zuriglim MV 2mg/500mg/0.3mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zuriglim MV 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing. Administer on an empty stomach.

Common Side effects of Zuriglim MV 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Zuriglim MV 2mg/500mg/0.3mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Zuriglim MV 2mg/500mg/0.3mg Tablet on an empty stomach.

How Zuriglim MV 2mg/500mg/0.3mg Tablet works:

Each Zuriglim MV tablet (2mg/500mg/0.3mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Zuriglim MV 2mg/500mg/0.3mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zuriglim MV 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zuriglim MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from operating a vehicle if such symptoms arise.

KidneyKidneyUNSAFE

The use of Zuriglim MV 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be forgone. Medical advice is recommended. In patients exhibiting severe kidney disease, Zuriglim MV 2mg/500mg/0.3mg tablets are contraindicated.

LiverLiverCAUTION

Patients with liver impairment should use Zuriglim MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate hepatic dysfunction, initiation with a reduced dose is typical; however, its use is contraindicated in individuals with severe liver disease.

What if you forget to take Zuriglim MV 2mg/500mg/0.3mg Tablet :

Should you forget a Zuriglim MV 2mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zuriglim MV 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Zuriglim MV 2mg/500mg/0.3mg Tablet

Zuriglim MV 2mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Zuriglim MV 2mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infections.
Zuriglim MV 2mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any component or excipient. They should also be avoided in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Zuriglim MV 2mg/500mg/0.3mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Zuriglim MV 2mg/500mg/0.3mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Zuriglim MV 2mg/500mg/0.3...
60
MRP 70
14% off